Spots Global Cancer Trial Database for Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
Official Title: A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to Assess the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
Study ID: NCT02000622
Study Description
Brief Summary: This open label, randomised, controlled, multi-centre phase III study will assess the efficacy and safety of single agent olaparib vs standard of care based on physician's choice of capecitabine, vinorelbine or eribulin in metastatic breast cancer patients with gBRCA 1/2 mutations.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, San Diego, California, United States
Research Site, Santa Rosa, California, United States
Research Site, Whittier, California, United States
Research Site, Denver, Colorado, United States
Research Site, New Haven, Connecticut, United States
Research Site, Washington, District of Columbia, United States
Research Site, Jacksonville, Florida, United States
Research Site, Orlando, Florida, United States
Research Site, Plantation, Florida, United States
Research Site, Columbus, Georgia, United States
Research Site, Marietta, Georgia, United States
Research Site, Chicago, Illinois, United States
Research Site, Niles, Illinois, United States
Research Site, Wichita, Kansas, United States
Research Site, Lafayette, Louisiana, United States
Research Site, Boston, Massachusetts, United States
Research Site, Boston, Massachusetts, United States
Research Site, Boston, Massachusetts, United States
Research Site, Detroit, Michigan, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, Rochester, Minnesota, United States
Research Site, Saint Louis Park, Minnesota, United States
Research Site, Jackson, Mississippi, United States
Research Site, Columbia, Missouri, United States
Research Site, Saint Louis, Missouri, United States
Research Site, Lebanon, New Hampshire, United States
Research Site, Commack, New York, United States
Research Site, Harrison, New York, United States
Research Site, New York, New York, United States
Research Site, New York, New York, United States
Research Site, Rockville Centre, New York, United States
Research Site, Syracuse, New York, United States
Research Site, Cincinnati, Ohio, United States
Research Site, Cleveland, Ohio, United States
Research Site, Cleveland, Ohio, United States
Research Site, Portland, Oregon, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Sayre, Pennsylvania, United States
Research Site, Germantown, Tennessee, United States
Research Site, Houston, Texas, United States
Research Site, Tyler, Texas, United States
Research Site, Burlington, Vermont, United States
Research Site, Plovdiv, , Bulgaria
Research Site, Plovdiv, , Bulgaria
Research Site, Sofia, , Bulgaria
Research Site, Sofia, , Bulgaria
Research Site, Sofia, , Bulgaria
Research Site, Sofia, , Bulgaria
Research Site, Varna, , Bulgaria
Research Site, Vratza, , Bulgaria
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Changchun, , China
Research Site, Changsha, , China
Research Site, Chengdu, , China
Research Site, Dalian, , China
Research Site, Guangzhou, , China
Research Site, Hangzhou, , China
Research Site, Harbin, , China
Research Site, Nanjing, , China
Research Site, Shanghai, , China
Research Site, Shanghai, , China
Research Site, Shenyang, , China
Research Site, Tianjin, , China
Research Site, Brno, , Czechia
Research Site, Olomouc, , Czechia
Research Site, Praha 2, , Czechia
Research Site, Caen Cedex, , France
Research Site, Montpellier, , France
Research Site, Rouen, , France
Research Site, Strasbourg Cedex, , France
Research Site, Villejuif, , France
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Nyíregyháza, , Hungary
Research Site, Veszprém, , Hungary
Research Site, Bologna, , Italy
Research Site, Napoli, , Italy
Research Site, Padova, , Italy
Research Site, Roma, , Italy
Research Site, Roma, , Italy
Research Site, Rozzano, , Italy
Research Site, Chuo-ku, , Japan
Research Site, Chuo-ku, , Japan
Research Site, Fukuoka-shi, , Japan
Research Site, Kagoshima-shi, , Japan
Research Site, Nagoya-shi, , Japan
Research Site, Osaka-city, , Japan
Research Site, Sapporo-shi, , Japan
Research Site, Shinagawa-ku, , Japan
Research Site, Suita-city, , Japan
Research Site, Cheongju-si, , Korea, Republic of
Research Site, Daegu, , Korea, Republic of
Research Site, Incheon, , Korea, Republic of
Research Site, Seongnam-si, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Estado de México, , Mexico
Research Site, Merida, , Mexico
Research Site, Merida, , Mexico
Research Site, Mexico, , Mexico
Research Site, Mérida, , Mexico
Research Site, San Juan del Rio, , Mexico
Research Site, Cusco, , Peru
Research Site, Lima, , Peru
Research Site, Lima, , Peru
Research Site, Lima, , Peru
Research Site, Lima, , Peru
Research Site, Lima, , Peru
Research Site, San Borja, , Peru
Research Site, Elbląg, , Poland
Research Site, Gdańsk, , Poland
Research Site, Grzepnica, , Poland
Research Site, Tarnobrzeg, , Poland
Research Site, Warszawa, , Poland
Research Site, Warszawa, , Poland
Research Site, Łódź, , Poland
Research Site, Bucharest, , Romania
Research Site, Bucuresti, , Romania
Research Site, Bucuresti, , Romania
Research Site, Cluj Napoca, , Romania
Research Site, Cluj-Napoca, , Romania
Research Site, Arkhangelsk, , Russian Federation
Research Site, Ivanovo, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Omsk, , Russian Federation
Research Site, Saint Petersburg, , Russian Federation
Research Site, Saint Petersburg, , Russian Federation
Research Site, Saint Petersburg, , Russian Federation
Research Site, Saransk, , Russian Federation
Research Site, St-Petersburg, , Russian Federation
Research Site, St.Petersburg, , Russian Federation
Research Site, Yaroslavl, , Russian Federation
Research Site, Barcelona, , Spain
Research Site, Córdoba, , Spain
Research Site, Granada, , Spain
Research Site, Madrid, , Spain
Research Site, Majadahonda, , Spain
Research Site, Oviedo, , Spain
Research Site, Sevilla, , Spain
Research Site, Valencia, , Spain
Research Site, Zaragoza, , Spain
Research Site, Bern, , Switzerland
Research Site, Lausanne, , Switzerland
Research Site, Zürich, , Switzerland
Research Site, Kaohsiung, , Taiwan
Research Site, Taichung, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taoyuan, , Taiwan
Research Site, Adana, , Turkey
Research Site, Ankara, , Turkey
Research Site, Edirne, , Turkey
Research Site, Gaziantep, , Turkey
Research Site, Istanbul, , Turkey
Research Site, Izmir, , Turkey
Research Site, Kayseri, , Turkey
Research Site, Konya, , Turkey
Research Site, Mersin, , Turkey
Research Site, Aberdeen, , United Kingdom
Research Site, Colchester, , United Kingdom
Research Site, Coventry, , United Kingdom
Research Site, London, , United Kingdom
Research Site, Manchester, , United Kingdom
Research Site, Plymouth, , United Kingdom
Contact Details
Name: Mark Robson, MD
Affiliation: Memorial Sloan-Kettering Cancer Center, New York
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
